Noa-Rose's Meningitis Battle: Vaccine's Role & Teen Boosters

On March 26, in December 2022, four-year-old Noah Rose from Blackwood and Carefully County

battled Moningo Cockle type B. Menonjitis, despite full vaccination.

The little girl spent two weeks on a high-dependency ward, held lifeless by her parents as doctors

fought to stabilize her.

Her ordeal started with leg pain after a part trip, escalating to a 40-degree Celsius fever,

rash, and vomiting.

Noah's first suspect is scarlet fever and sent her home, but she soon became unresponsive,

leading to a lumbar puncture that confirmed the rare men be.

Infection.

Noah Rose's family describes it as their worst nightmare, with mum Emma, now an ambassador

for meningitis now.

As seven years old, the girl lives with epilepsy, fatigue, and developmental delays, shifting

her parents into carers overnight.

The vaccine has slashed men be cases by 75% in infants since 2015, though not foolproof.

Charity experts call Noah Rose's case extremely rare, and stress it likely reduced her illness

as severity, crediting shots for her survival.

Recent outbreaks, like one in Kent and a student's death, fuel calls for teen boosters by 2030.

Governments follow expert advice, sharing resources on symptoms, and urging quick action

to spot fever, headache, or rash early.